Refine by
Viral Vector Articles & Analysis
44 articles found
For biologics such as monoclonal antibodies, recombinant proteins, and viral vectors, downstream processing can account for the majority of production costs, making process optimization both a scientific challenge and a commercial necessity. ...
The process of immortalization typically involves the introduction of specific oncogenes or the use of viral vectors to enhance the longevity of the cells. One notable approach is the use of the simian virus 40 (SV40) large T antigen, which interferes with the normal cellular senescence pathway, enabling podocytes to bypass their replicative limits. ...
With their ability to deliver genetic material into cells effectively, adenoviruses serve as valuable vectors in various biomedical applications. To harness their potential, specialized adenovirus production services have emerged, catering to the increasing demand for high-quality viral vectors. ...
These services cater to research labs by providing high-quality, ready-to-use viral vectors, thereby streamlining the experimental process. Utilizing advanced technologies and optimized protocols, these services ensure that researchers receive AAVs that meet their experimental requirements in terms of serotype, titer, and purity. ...
Advantages of Lentivirus as a Delivery System Lentiviruses, a subclass of retroviruses, play a crucial role in the delivery of CRISPR/Cas9 components. Unlike other viral vectors, lentiviruses can transduce both dividing and non-dividing cells, broadening the scope of potential applications. ...
Viral vectors are pivotal tools in gene therapy, enabling the delivery of genetic material into host cells. ...
This gene is then isolated and inserted into a vector, which is a DNA molecule that can replicate within a host organism. Commonly used vectors include plasmids, which are circular DNA molecules, and viral vectors. The choice of vector depends on the type of host organism used for protein production. ...
Traditional delivery systems, including viral vectors, come with limitations such as immunogenicity, potential toxicity, and limited payload capacity. ...
Advances in delivery methods, such as using viral vectors that specifically target certain cell types, also help limit the potential for unintended genetic modifications. ...
Advances in delivery mechanisms, such as viral vectors and nanoparticles, are enhancing the efficiency of gene transfer into T cells. ...
These technologies allow researchers to predict viral behavior, identify potential targets, and expedite the drug development process. ...
AAV particles are naturally occurring viruses that have been modified to serve as vectors for gene transfer. These vectors are uniquely appealing due to their non-pathogenic nature, ability to transduce both dividing and non-dividing cells, and the capacity to induce long-lasting expression of the therapeutic gene. By utilizing premade AAV particles, researchers ...
There are different methods to induce cancer in zebrafish, such as chemical mutagenesis, radiation mutagenesis, insertional mutagenesis (which can be transposon-based), or viral vector mutagenesis. An emerging approach for translational cancer research is patient-derived xenografts in zebrafish embryos (zPDX). ...
One common biological system is viral gene delivery, where the viral vectors are modified to carry the genes and deliver them to the target cells. ...
Overcoming issues related to mRNA stability and cellular uptake remains a critical area of focus for researchers, who are exploring various delivery methods such as lipid nanoparticles and viral vectors to enhance mRNA delivery efficiency. Despite these challenges, the potential benefits of custom mRNA production are substantial, promising groundbreaking ...
Today, the delivery systems used for CRISPR/Cas9 are mainly divided into two categories: viral vectors and non-viral vectors. Adeno-associated virus (AAV) is the representative of viral vectors. Although viral vectors show high transfection efficiency, their ...
Our miRNA overexpression stable cell lines are constructed by lentivirus transduction or non-viral plasmid transfection of vectors optimized by our scientists to enable expression and maturation of miRNAs inside cells. ...
One such system employs reporter lentiviral particles, using the power of viral vectors to inject and express these markers in target cells. This article delves deep into the concept of reporter lentiviral particles and their remarkable contribution to biomedical research. ...
To mitigate sequence diversity, vaccine design focuses on highly conserved domains, especially those targeted by broadly neutralizing antibodies on viral envelope glycoproteins. Due to the high conservation of the backbone region of HA2, it represents an excellent target.Hepatitis VirusesInfection with hepatitis C virus (HCV) can lead to liver diseases such as cirrhosis or ...
Compared with viral vectors, non-viral delivery vectors are easier to scale up and have the ability to solve the most critical safety issues. Thanks to the LNP-mRNA vaccine that came to the fore during the COVID-19 pandemic, lipid nanoparticles (LNP) are undoubtedly the most advanced and widely studied non-viral ...